AbbVie stock heads toward October 30 results after 10.2 percent growth
Published on 10/05/2026 at 15:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AbbVie Inc. (ISIN US00287Y1091) stock was last at USD 262.82 on the NYSE on October 2, 2026, up 1.11 percent from the prior session. The next major company checkpoint is October 30, when AbbVie will release third-quarter 2026 results before the market opens, according to Morningstar on October 1, 2026. That date puts the companys post-Humira growth strategy back under direct scrutiny.
October 30 sets the next checkpoint
The October 30 release will give investors a fresh read on Skyrizi, Rinvoq, Humira and the early commercial outlook for Juvmo. Ticker Scout identifies the latest reported period as the second quarter ended June 30, 2026, with revenue of USD 16.990 billion and adjusted diluted EPS of USD 3.65.
The second-quarter revenue figure was 10.2 percent higher than a year earlier, while adjusted EPS increased 22.9 percent, according to Ticker Scout. The comparison matters because AbbVie is using newer medicines to offset pressure on legacy products.
Consensus leaves limited distance
MarketBeat reports a Moderate Buy consensus from 31 brokerages, including 23 Buy ratings, two Strong Buy ratings and six Hold ratings. The average one-year price target is USD 272.66, which lies 3.75 percent above the October 2 price of USD 262.82.
The same analyst overview lists third-quarter adjusted EPS guidance of USD 3.84-3.88 and full-year 2026 adjusted EPS expectations of USD 14.05. The main counterweight is execution: Juvmo must build demand, while Humira erosion and competition can pressure the established portfolio.
Stock stays below yearly high
AbbVie stock was last at USD 262.82 on October 2, 2026, at 4:02 p.m. ET on the NYSE. The price stood USD 6.57 below the 52-week high of USD 269.39, while market capitalization was USD 464.3 billion.
AbbVie stock key figures
- Company: AbbVie Inc.
- ISIN: US00287Y1091
- Ticker: ABBV
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:02 p.m. ET): USD 262.82
- Market capitalization: USD 464.3 billion (as of October 2, 2026)
- 52-week range: USD 190.75-269.39 (as of October 2, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
Upcoming dates for AbbVie stock
- October 15, 2026: Ex-dividend date for the USD 1.73 quarterly dividend
- October 30, 2026: Third-quarter 2026 results before the market opens
